Alvotech Makes It Four With Denosumab Trial

Study Begins For Firm’s AVT03 Proposed Prolia/Xgeva Biosimilar

 
• By David Wallace
  
Number 4 Four Pool Ball Cue
Alvotech is cueing up a fourth biosimilar clinical trial program • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products